Exhaled Volatile Organic Compounds Detection in Pneumonia Screening: A Comprehensive Meta-analysis

Area of Science:

• Respiratory Medicine
• Diagnostic Technology
• Biomarker Discovery

Background:

• Pneumonia is a common lower respiratory infection requiring early diagnosis for effective treatment.
• Traditional pneumonia diagnostics like chest imaging have limitations.
• Exhaled volatile organic compounds (VOCs) detection is an emerging non-invasive technique for pneumonia screening.

Purpose of the Study:

• To systematically evaluate the diagnostic performance of exhaled VOCs detection for pneumonia.
• To perform a meta-analysis of existing diagnostic studies on exhaled VOCs for pneumonia.

Main Methods:

• Systematic literature search of PubMed, Embase, Cochrane Library, and Web of Science up to March 2024.
• Inclusion of diagnostic studies evaluating exhaled VOCs for pneumonia diagnosis.
• Meta-analysis using a bivariate model for sensitivity and specificity.

Main Results:

• 14 studies included, demonstrating high diagnostic performance for exhaled VOCs detection in pneumonia screening.
• Pooled sensitivity: 0.94 (95% CI: 0.92-0.95), Pooled specificity: 0.83 (95% CI: 0.81-0.84).
• Area under the summary ROC curve (AUC) of 0.96, indicating excellent diagnostic accuracy.

Conclusions:

• Exhaled VOCs detection is a potentially effective and non-invasive screening method for pneumonia.
• This technique may facilitate future pneumonia diagnosis.
• Further large-scale, high-quality studies are needed to confirm clinical utility.